| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Ammon B Peck | |
| Cuong Q Nguyen | |||
| P2860 | cites work | Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations | Q21195408 |
| Interleukin-23 drives innate and T cell-mediated intestinal inflammation | Q24677051 | ||
| Genetic aspects of Sjögren's syndrome | Q24793991 | ||
| Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate | Q24796641 | ||
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
| Primary Sjögren's syndrome and deficiency of ICA69 | Q28207888 | ||
| Complexes of tetraspanins with integrins: more than meets the eye | Q28210099 | ||
| Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye | Q28214408 | ||
| Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
| Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study | Q28270236 | ||
| A genome-wide association study identifies IL23R as an inflammatory bowel disease gene | Q28270603 | ||
| A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage | Q28287540 | ||
| TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells | Q28296956 | ||
| Acetylcholine-evoked calcium mobilization and ion channel activation in human labial gland acinar cells from patients with primary Sjögren's syndrome | Q28344891 | ||
| Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome | Q28587895 | ||
| Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis | Q28590287 | ||
| Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency? | Q77425439 | ||
| Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome | Q77530748 | ||
| Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice | Q77653070 | ||
| Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome | Q77846439 | ||
| Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome | Q81129079 | ||
| Programmed cell death of peripheral blood B cells determined by laser scanning cytometry in Sjögren's syndrome with a special emphasis on BAFF | Q81205499 | ||
| Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease | Q82263589 | ||
| PANTHER: a library of protein families and subfamilies indexed by function | Q29547480 | ||
| A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 | Q29547855 | ||
| Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages | Q29547871 | ||
| Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation | Q29614224 | ||
| Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain | Q29614225 | ||
| IL-17 family cytokines and the expanding diversity of effector T cell lineages | Q29619361 | ||
| The pharmacology of phosducin | Q32023008 | ||
| Diagnostic potential of tear proteomic patterns in Sjögren's syndrome | Q33216985 | ||
| In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response | Q33349381 | ||
| Androgens and dry eye in Sjögren's syndrome | Q33692681 | ||
| Autoantibodies in connective tissue diseases: clinical significance and analysis of target autoantigens. | Q33704265 | ||
| Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome | Q33798937 | ||
| Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome | Q34108411 | ||
| Approaches to the treatment of Sjögren's syndrome | Q34112575 | ||
| Abnormal protein profiles in tears with dry eye syndrome | Q34218114 | ||
| Sjögren's syndrome: immunological response underlying the disease | Q34499212 | ||
| Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group | Q34523084 | ||
| Tearful relationships? Sex, hormones, the lacrimal gland, and aqueous-deficient dry eye. | Q34600425 | ||
| Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update | Q34720542 | ||
| Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice | Q34941147 | ||
| Location is everything: lipid rafts and immune cell signaling. | Q35077421 | ||
| Antibodies against alpha-fodrin in Sjögren's syndrome | Q35172013 | ||
| New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers | Q35213880 | ||
| Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study. | Q35552228 | ||
| Lymphoproliferation in autoimmunity and Sjögren’s syndrome | Q35553396 | ||
| Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma. | Q35679988 | ||
| Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome | Q35769293 | ||
| Role of Id proteins in B lymphocyte activation: new insights from knockout mouse studies | Q35797150 | ||
| Altered autoantigen structure in Sjögren's syndrome: implications for the pathogenesis of autoimmune tissue damage | Q35798719 | ||
| Altered structure of autoantigens during apoptosis | Q35839758 | ||
| Apoptosis and estrogen deficiency in primary Sjögren syndrome | Q35864672 | ||
| Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes | Q36363024 | ||
| DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis | Q36365577 | ||
| Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity | Q36375304 | ||
| Sjogrens syndrome--the non-apoptotic model of glandular hypofunction. | Q36440848 | ||
| Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome | Q36495620 | ||
| Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. | Q51990664 | ||
| Central nervous system involvement in Sjögren's syndrome: evidence from neuropsychological testing and HMPAO-SPECT. | Q52028986 | ||
| Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune NOD mice. | Q52040437 | ||
| A T cell intrinsic role of Id3 in a mouse model for primary Sjogren's syndrome. | Q52086700 | ||
| Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy. | Q52129767 | ||
| Neuropsychiatric dysfunction in primary Sjögren's syndrome. | Q52205499 | ||
| Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. | Q52226171 | ||
| Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. | Q52870535 | ||
| Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome. | Q53622590 | ||
| Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. | Q54116642 | ||
| Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis. | Q54573527 | ||
| Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. | Q55047291 | ||
| Sjögren's syndrome | Q55921808 | ||
| Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: Correlation with certain features of immune hyperactivity and factors associated | Q55970265 | ||
| CD40, CD154, Bax and Bcl-2 Expression in Sjogren's Syndrome Salivary Glands: a Putative Anti-Apoptotic Role During its Effector Phases | Q55970266 | ||
| Fas-Induced Apoptosis Is a Rare Event in Sjögren’s Syndrome | Q55970267 | ||
| Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells | Q57352505 | ||
| Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes | Q57693415 | ||
| Salivary Gland Cytokine Expression in NOD and Normal BALB/c Mice | Q60717055 | ||
| Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1 | Q60787779 | ||
| PPAR regulates the function of human dendritic cells primarily by altering lipid metabolism | Q62661545 | ||
| Autoantibodies reacting with poly(ADP-ribose) and with a zinc-finger functional domain of poly(ADP-ribose) polymerase involved in the recognition of damaged DNA | Q64389667 | ||
| Pathogenesis of Sjögren's syndrome | Q67855813 | ||
| Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome | Q68795035 | ||
| Murine models of systemic lupus erythematosus | Q69894910 | ||
| Sjögren's syndrome in MRL/l and MRL/n mice | Q70465438 | ||
| Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice | Q71032473 | ||
| Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome | Q71245386 | ||
| Expression of ductal Fas antigen in sialoadenitis of Sjögren's syndrome | Q71538134 | ||
| HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome | Q71671383 | ||
| Cytokine gene expression and autoantibody production in Sjögren's syndrome of MRL/lpr mice | Q71771913 | ||
| TCR in Fas-sensitive T cells from labial salivary glands of patients with Sjögren's syndrome | Q71968438 | ||
| Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome | Q72329693 | ||
| MRL/lpr mice produce anti-Ro 52,000 MW antibodies: detection, analysis of specificity and site of production | Q72410235 | ||
| In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity | Q72857248 | ||
| Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjögren's syndrome | Q73155009 | ||
| IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus | Q73228748 | ||
| Association of the glutathione S-transferase M1 homozygous null genotype with susceptibility to Sjögren's syndrome in Japanese individuals | Q73313537 | ||
| The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice | Q73397204 | ||
| Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis? | Q73711211 | ||
| Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis | Q73830720 | ||
| Identification of four new quantitative trait loci regulating arthritis severity and one new quantitative trait locus regulating autoantibody production in rats with collagen-induced arthritis | Q73904640 | ||
| Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome | Q74024000 | ||
| A novel NOD-derived murine model of primary Sjögren's syndrome | Q74060238 | ||
| Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy | Q74214657 | ||
| Mechanisms of neonatal tolerance induced in an animal model for primary Sjögren's syndrome by intravenous administration of autoantigen | Q74267251 | ||
| Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background | Q74455359 | ||
| Androgen deficiency & dry eye syndromes | Q76385884 | ||
| Sjögren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies | Q36664684 | ||
| Dysfunctional neural regulation of lacrimal gland secretion and its role in the pathogenesis of dry eye syndromes. | Q36704597 | ||
| Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation | Q36732543 | ||
| Detection of Epstein-Barr virus genomes in normal human lacrimal glands | Q37182949 | ||
| Association of a new allele of the TAP2 gene, TAP2*Bky2 (Val577), with susceptibility to Sjögren's syndrome | Q38342360 | ||
| Successful Treatment of Dry Mouth and Dry Eye Symptoms in Sjögren's Syndrome Patients With Oral Pilocarpine: A Randomized, Placebo-Controlled, Dose-Adjustment Study | Q39344788 | ||
| Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. | Q39953212 | ||
| Functional analysis of the glaucoma-causing TIGR/myocilin protein: integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion | Q40319055 | ||
| Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome | Q40510938 | ||
| Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay | Q40521443 | ||
| Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. | Q40560477 | ||
| Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. | Q40906130 | ||
| Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency | Q41199852 | ||
| Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome | Q41463203 | ||
| Sex hormones and Sjögren's syndrome. | Q41591330 | ||
| Autoimmunity against a tissue kallikrein in IQI/Jic Mice: a model for Sjogren's syndrome | Q42640603 | ||
| Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. | Q42985694 | ||
| The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome | Q43050637 | ||
| IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome | Q43663287 | ||
| A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca | Q43937871 | ||
| Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission. | Q44692210 | ||
| Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome | Q44805120 | ||
| Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome | Q44930027 | ||
| Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder. | Q45141258 | ||
| Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis | Q45878905 | ||
| Serum lipid levels in Sjögren's syndrome | Q45888751 | ||
| Androgen support of lacrimal gland function in the female rabbit | Q46121203 | ||
| Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in nod mice | Q46414072 | ||
| Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies. | Q46933726 | ||
| Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome | Q47389814 | ||
| Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome | Q47739038 | ||
| Up-regulated gene expression in the conjunctival epithelium of patients with Sjögren's syndrome | Q47807754 | ||
| Aberrant expression and potential function for parotid secretory protein (PSP) in the NOD (non-obese diabetic) mouse | Q47947136 | ||
| Infiltrating lymphocyte populations and cytokine production in the salivary and lacrimal glands of autoimmune NOD mice. | Q47947542 | ||
| Signal transduction pathways activated by cholinergic and alpha 1-adrenergic agonists in the lacrimal gland. | Q47947918 | ||
| Identification and hormonal control of sex steroid receptors in the eye. | Q47947955 | ||
| Meibomian gland dysfunction in patients with Sjögren syndrome. | Q50870035 | ||
| Gender and androgen treatment influence the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice. | Q50913212 | ||
| Anxiety and depression in patients with primary Sjögren's syndrome. | Q51083245 | ||
| Sjögren's syndrome-like disease of C57BL/6.NOD-Aec1 Aec2 mice: gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus. | Q51790192 | ||
| A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. | Q51821296 | ||
| Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches. | Q51824092 | ||
| P433 | issue | 1 | |
| P921 | main subject | pathophysiology | Q1135939 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 11-27 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | The Ocular Surface | Q15764153 |
| P1476 | title | Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease | |
| P478 | volume | 7 |
| Q33627160 | A case report of Sjögren syndrome manifesting bilateral basal ganglia lesions |
| Q26824039 | Advances in the Aetiophatogenesis of Sjögren's Syndrome: a Literature Review |
| Q36395133 | Age-Related Conjunctival Disease in the C57BL/6.NOD-Aec1Aec2 Mouse Model of Sjögren Syndrome Develops Independent of Lacrimal Dysfunction. |
| Q37737497 | Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells |
| Q36806556 | Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren Syndrome |
| Q48943977 | Anxiety and depression in patients with dry eye syndrome. |
| Q64071033 | Association between Periodontal Disease and Subsequent Sjögren's Syndrome: A Nationwide Population-Based Cohort Study |
| Q50670959 | Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome. |
| Q35911677 | Beyond the Glands: An in-Depth Perspective of Neurological Manifestations in Sjögren's Syndrome |
| Q33758184 | Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice |
| Q92006109 | Characteristics of dry eye in patients with pre-existing Sjögren's syndrome according to the revised 2016 ACR-EULAR classification criteria |
| Q38197287 | Classification criteria and treatment modalities in primary Sjögren's syndrome |
| Q33837769 | Coherent somatic mutation in autoimmune disease |
| Q35006085 | Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome |
| Q34479267 | Current concepts: mouse models of Sjögren's syndrome |
| Q36907644 | Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice. |
| Q36908864 | Diagnostic performance of a tear protein panel in early dry eye |
| Q34154774 | Distinct dacryoadenitides autoadoptively transferred to rabbits by different subpopulations of lymphocytes activated ex vivo |
| Q50850940 | Evaluation of dry eye and meibomian gland dysfunction with meibography in vitiligo. |
| Q55426876 | Expression of Gαq Is Decreased in Lymphocytes from Primary Sjögren's Syndrome Patients and Related to Increased IL-17A Expression. |
| Q35647194 | Expression of interleukin-22 in Sjögren's syndrome: significant correlation with disease parameters |
| Q35221347 | Gene expression profiling of early-phase Sjögren's syndrome in C57BL/6.NOD-Aec1Aec2 mice identifies focal adhesion maturation associated with infiltrating leukocytes |
| Q36133208 | Growth Arrest-Specific 6 Protein in Patients with Sjögren Syndrome: Determination of the Plasma Level and Expression in the Labial Salivary Gland |
| Q41685645 | Hepatitis C virus core and NS3 antigens induced conjunctival inflammation via toll-like receptor-mediated signaling |
| Q39935470 | Human T-Lymphotrophic Virus Type-I: A Unique Association with Myelopathy in Sjögren's Syndrome |
| Q36652620 | IL-22 regulation of functional gene expression in salivary gland cells |
| Q34448523 | IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer |
| Q35812987 | Influence of sex hormones and genetic predisposition in Sjögren's syndrome: a new clue to the immunopathogenesis of dry eye disease |
| Q34028408 | Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. |
| Q62398517 | NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis |
| Q37282406 | New insight on the Xq28 association with systemic sclerosis |
| Q37605983 | Ocular surface disease and dacryoadenitis in aging C57BL/6 mice. |
| Q34614045 | Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer |
| Q37830007 | Proteome analysis of biological fluids from autoimmune-rheumatological disorders |
| Q34127741 | Proteomic analysis in pterygium; upregulated protein expression of ALDH3A1, PDIA3, and PRDX2. |
| Q34473302 | Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome |
| Q41592357 | Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome |
| Q88639474 | Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjögren syndrome |
| Q37497899 | Sexual dimorphic function of IL-17 in salivary gland dysfunction of the C57BL/6.NOD-Aec1Aec2 model of Sjögren's syndrome |
| Q36506691 | Sexual dimorphism in an animal model of Sjögren's syndrome: a potential role for Th17 cells |
| Q59805576 | Similar dysregulation of lupus-associated miRNAs in peripheral blood mononuclear cells and splenic lymphocytes in MRL/lpr mice |
| Q34629461 | Single-cell analysis reveals isotype-specific autoreactive B cell repertoires in Sjögren's syndrome |
| Q36243207 | Sjögren syndrome: what and where are we looking for? |
| Q88735143 | Subconjunctival dendrimer-drug therapy for the treatment of dry eye in a rabbit model of induced autoimmune dacryoadenitis |
| Q37374838 | T helper cytokines in dry eye disease |
| Q33831656 | Tear cathepsin S as a candidate biomarker for Sjögren's syndrome |
| Q33590297 | Temporal histological changes in lacrimal and major salivary glands in mouse models of Sjogren's syndrome |
| Q31070967 | Text-mining applied to autoimmune disease research: the Sjögren's syndrome knowledge base |
| Q36983628 | The Interferon-Signature of Sjögren's Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases |
| Q26825196 | The clinical relevance of animal models in Sjögren's syndrome: the interferon signature from mouse to man |
| Q35535169 | The important role of T cells and receptor expression in Sjögren's syndrome |
| Q34764453 | Translational models of ocular disease |
Search more.